We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Read MoreHide Full Article
The latest trading session saw Tenet Healthcare (THC - Free Report) ending at $119.51, denoting a -1.39% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.91%. Elsewhere, the Dow saw a downswing of 1.5%, while the tech-heavy Nasdaq depreciated by 1.96%.
The the stock of hospital operator has fallen by 3.95% in the past month, lagging the Medical sector's loss of 1.88% and overreaching the S&P 500's loss of 7.38%.
Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. On that day, Tenet Healthcare is projected to report earnings of $3.10 per share, which would represent a year-over-year decline of 3.73%. Meanwhile, our latest consensus estimate is calling for revenue of $5.18 billion, down 3.53% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.03 per share and revenue of $20.84 billion, which would represent changes of +1.26% and +0.87%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 6.92% higher. As of now, Tenet Healthcare holds a Zacks Rank of #3 (Hold).
In terms of valuation, Tenet Healthcare is presently being traded at a Forward P/E ratio of 10.07. For comparison, its industry has an average Forward P/E of 9.77, which means Tenet Healthcare is trading at a premium to the group.
One should further note that THC currently holds a PEG ratio of 0.92. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Medical - Hospital industry was having an average PEG ratio of 1.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 162, this industry ranks in the bottom 36% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading session saw Tenet Healthcare (THC - Free Report) ending at $119.51, denoting a -1.39% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.91%. Elsewhere, the Dow saw a downswing of 1.5%, while the tech-heavy Nasdaq depreciated by 1.96%.
The the stock of hospital operator has fallen by 3.95% in the past month, lagging the Medical sector's loss of 1.88% and overreaching the S&P 500's loss of 7.38%.
Investors will be eagerly watching for the performance of Tenet Healthcare in its upcoming earnings disclosure. On that day, Tenet Healthcare is projected to report earnings of $3.10 per share, which would represent a year-over-year decline of 3.73%. Meanwhile, our latest consensus estimate is calling for revenue of $5.18 billion, down 3.53% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $12.03 per share and revenue of $20.84 billion, which would represent changes of +1.26% and +0.87%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 6.92% higher. As of now, Tenet Healthcare holds a Zacks Rank of #3 (Hold).
In terms of valuation, Tenet Healthcare is presently being traded at a Forward P/E ratio of 10.07. For comparison, its industry has an average Forward P/E of 9.77, which means Tenet Healthcare is trading at a premium to the group.
One should further note that THC currently holds a PEG ratio of 0.92. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Medical - Hospital industry was having an average PEG ratio of 1.
The Medical - Hospital industry is part of the Medical sector. With its current Zacks Industry Rank of 162, this industry ranks in the bottom 36% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.